Carrie Brownstein's Insider Trades & SAST Disclosures

Carrie Brownstein's most recent trade in Shattuck Labs Inc was a trade of 27,700 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 21, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Shattuck Labs Inc
Carrie Brownstein Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2024 27,700 27,700 - - Stock Option (Right to Buy)
Shattuck Labs Inc
Carrie Brownstein Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 May 2023 40,258 40,258 - - Stock Option (Right to Buy)
Zentalis Pharmaceuticals Inc
Carrie Brownstein Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2023 23,687 23,687 - - Stock Option (Right to Buy)
Zentalis Pharmaceuticals Inc
Carrie Brownstein Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2023 16,313 116,313 - 0 Common Stock
Shattuck Labs Inc
Carrie Brownstein Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Nov 2021 10,467 10,467 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades